Jump to content

Edward Khantzian

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Tadarrius Bean (talk | contribs) at 22:05, 25 March 2024. The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Edward Khantzian was a professor of psychiatry at Harvard Medical School.[1] Beginning in the 1970s,[2] he developed a progressively more coherent and empirically-grounded self-medication hypothesis of drug abuse,[3][4] which states that individuals use drugs in an attempt to self-medicate states of distress and suffering.[5]

Dr. Khantzian is a first generation Armenian-American born in Haverhill Massachusetts. His parents were born in Turkey, his father immigrated to the United States in 1912. Khantzian's mother survived the Armenian genocide that started in 1915, moving to the U.S. in the late 1920s. Edward Khantzian was born in 1935 and grew up in Haverhill, a shoe town, where both parents worked in the then flourishing shoe industry.

Educated in local school systems, he began his university studies in the Evening Divisions of Merrimack College and Boston University, graduating from the latter in 1958. After working as a technical writer for Raytheon for one year, he commenced his medical training at Albany Medical College in 1959, and graduated in 1963. He completed an internship at Rhode Island Hospital in Providence, Rhode Island. Subsequently, he commenced his training in psychiatry at the Massachusetts Mental Health Mental Center, a Harvard Medical School-affiliated facility. He joined the staff and Harvard teaching faculty at Cambridge Hospital, where he worked for most of his career. He completed psychoanalytic training at the Boston Psychoanalytic Society and Institute in 1973.

Starting early in his career he became involved in multiple clinical and investigative studies of addiction, with an emphasis on pursuing a psychodynamic understanding of the psychological vulnerabilities that predispose to addictive disorders.[6] Considered a pioneer in addiction studies, he gained recognition for his development of the self-medication hypothesis. He also developed modified psychodynamic individual and group treatments for alcohol and other drug dependent individuals,[7] as well as exploring ingredients that seem to make 12-step programs effective.

Khantzian is a founding member and past president of the American Academy of Addiction Psychiatry. In 2016, the Massachusetts Psychiatric Society awarded Khantzian with their Lifetime Achievement Award.[8]

References

[edit]
  1. ^ "Harvard Catalyst Profiles: Edward John Khantzian, M.D." Harvard University. Archived from the original on January 2, 2015. Retrieved January 1, 2015.
  2. ^ Khantzian, Edward J.; Mack, John E.; Schatzberg, Alan F. (1974). "Heroin Use as an Attempt To Cope: Clinical Observations". American Journal of Psychiatry. 131 (2): 160–164. doi:10.1176/ajp.131.2.160. ISSN 0002-953X. PMID 4809043.
  3. ^ Khantzian, E. J. (1985). "The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence". American Journal of Psychiatry. 142 (11): 1259–1264. doi:10.1176/ajp.142.11.1259. ISSN 0002-953X. PMID 3904487.
  4. ^ Khantzian, Edward J. (1997). "The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications". Harvard Review of Psychiatry. 4 (5): 231–244. doi:10.3109/10673229709030550. ISSN 1067-3229. PMID 9385000. S2CID 39531697.
  5. ^ Fetting, Margaret (2012). Perspectives on Addiction: An Integrative Treatment Model with Clinical Case Studies (PDF). Thousand Oaks, California: SAGE. pp. 93–110. ISBN 9781412990998. Retrieved January 1, 2015.
  6. ^ Khantzian, E. J. (1987). "A Clinical Perspective of the Cause–Consequence Controversy in Alcoholic and Addictive Suffering". Journal of the American Academy of Psychoanalysis. 15 (4): 521–537. doi:10.1521/jaap.1.1987.15.4.521. ISSN 0090-3604. PMID 3312132.
  7. ^ Khantzian, Edward J. (2001). "Reflections on Group Treatments as Corrective Experiences for Addictive Vulnerability". International Journal of Group Psychotherapy. 51 (1): 11–20. doi:10.1521/ijgp.51.1.11.49729. ISSN 0020-7284. PMID 11191591. S2CID 46572660.
  8. ^ "Awards & Recognition - Edward Khantzian, MD: Lifetime Achievement Award". Cambridge Health Alliance. Retrieved 2020-07-27.
[edit]